SABR-Dual: a phase II/III trial of two-fraction versus five-fraction stereotactic radiotherapy for localized low- and favorable intermediate-risk prostate cancer
Article in BMC Cancer (April 2024)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Article in BMC Cancer (April 2024)
Article in Radiotherapy and Oncology (March 2024)
Article in World Journal of Urology (November 2023)